RCT 2012

Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial

Pauline Cho; Sin-Wan Cheung

Investigative ophthalmology & visual science

What does this source bring?

In ROMIO, the average axis gain was 0,36 mm in orthokeratology and 0,63 mm in the single vision group over 2 years.

78 children completed the study; unblinded users. Five people discontinued orthokeratology due to adverse events.

CLAIM-ROMIO

Scope of testing and verification

The role of the record
Source of the claim
Population
Children 6–10 years in Hong Kong
N
102
Geography
Hong Kong
Observation (months)
24
Comparator
Single vision glasses
Result
In ROMIO, the average axis gain was 0,36 mm in orthokeratology and 0,63 mm in the single vision group over 2 years.
Safety
Five treatment discontinuations due to adverse events; the study is too small to precisely evaluate rare infections.
Device/structure
Not applicable / not determined within the verified range
Publisher of the publication
Association for Research in Vision and Ophthalmology (ARVO)
Financing
Not determined within the proven range; see the declaration in full text.
Conflicts of interest
Not determined within the proven range. The absence of confirmation does not mean the absence of conflict.
DOI
10.1167/iovs.12-10565
PMID
22969068
What was checked
Bibliographic metadata and abstract in Europe PMC / PubMed; Crossref metadata
Date of verification
2026-09-09

This is the editorial card of the publication. The description does not replace the full text, supplementary data or instructions for a specific device.

Availability

Text size
100%
Contrast
Reading
SOURCE RECORD

Source record